Table 4.
Clinical and biochemical characteristics among subjects according to genotypes of C69T.
| T2DM (n = 164) | Controls (n = 165) | P value | |||||
|---|---|---|---|---|---|---|---|
| CC | CT | TT | CC | CT | TT | ||
| Age (years) | 61.93 ± 9.65 | 62.55 ± 10.10 | 62.04 ± 9.09 | 55.60 ± 11.50 | 54.51 ± 12.62 | 54.06 ± 11.55 | 0.958 |
| BMI (Kg/m²) | 27.99 ± 5.07 | 27.98 ± 5.53 | 27.58 ± 4.94 | 26.98 ± 7.32 | 27.05 ± 5.22 | 27.35 ± 4.72 | 0.992 |
| WHR | 0.97 ± 0.23 | 0.95 ± 0.65 | 0.95 ± 0.07 | 1.00 ± 0.87 | 0.88 ± 0.05 | 0.91 ± 0.07 | 0.544 |
| SBP (mm Hg) | 142.79 ± 20.84 | 143.76 ± 25.25 | 138.94 ± 27.58 | 137.26 ± 19.17 | 137.10 ± 20.16 | 140.63 ± 23.11 | 0.961 |
| DBP (mm Hg) | 79.20 ± 14.04 | 79.69 ± 11.35 | 75.96 ± 10.16 | 79.13 ± 10.06 | 80.43 ± 11.34 | 79.33 ± 10.64 | 0.256 |
| FPG (mmol/L) | 8.81 ± 3.27 | 8.49 ± 3.64 | 8.64 ± 3.72 | 5.63 ± 1.57 | 5.21 ± 1.03 | 5.35 ± 0.79 | 0.592 |
| HbA1c (mmol/mol) | 7.95 ± 2.29 | 8.11 ± 1.93 | 7.88 ± 2.32 | 5.92 ± 0.68 | 5.95 ± 0.55 | 5.96 ± 0.72 | 0.575 |
| LDL (mmol/L) | 2.32 ± 0.91 | 2.47 ± 0.97 | 2.26 ± 0.81 | 2.57 ± 1.00 | 2.54 ± 0.93 | 2.85 ± 0.86 | 0.916 |
| HDL (mmol/L) | 1.22 ± 0.49 | 1.32 ± 0.46 | 1.26 ± 0.50 | 1.28 ± 0.43 | 1.10 ± 0.39 | 1.18 ± 0.45 | 0.788 |
| TG (mmol/L) | 1.93 ± 1.60 | 1.56 ± 0.63 | 1.73 ± 0.99 | 1.23 ± 0.86 | 1.21 ± 0.62 | 1.48 ± 0.67 | 0.291 |
| Cholesterol (mmol/L) | 4.39 ± 1.26 | 4.44 ± 1.08 | 4.31 ± 1.05 | 4.41 ± 1.18 | 4.29 ± 1.18 | 4.69 ± 1.11 | 0.843 |
P value < 0.05, between T2DM and controls.